Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / NBY - Micro Cap Sees Premarket Buying Pressure


NBY - Micro Cap Sees Premarket Buying Pressure

A California-based %Biotech company turned heads Tuesday in early trading after the company announced that it secured ‘significant’ orders for their %DERMAdoctor ® Kakadu ® C 20% Vitamin C Serum with Ferulic Acid & Vitamin E.

This news made traders eager to get their hands on shares of %NovaBayPharmaceuticals () as the premarket bid at the time of writing is $0.103/share (+2.79% implied open for sellers). It should be an exciting session for this micro cap!

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare and skincare products. Its leading product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is proven in laboratory testing to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available direct to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.

Stock Information

Company Name: NovaBay Pharmaceuticals Inc.
Stock Symbol: NBY
Market: NYSE
Website: novabay.com

Menu

NBY NBY Quote NBY Short NBY News NBY Articles NBY Message Board
Get NBY Alerts

News, Short Squeeze, Breakout and More Instantly...